The addition of corticotropin-releasing hormone to 2-day low dose dexamethasone suppression test provides additional case detection.
Leen WehbehUla Abed AlwahabAlexandra MikhaelGeorgiana DobriDivya Yogi-MorrenLaurence KennedyAmir H HamrahianPublished in: Endocrine (2023)
The Dex-CRH Test provided additional case detection in 5/65 (7.7%) patients with CD. It resulted in one false-positive case compared to LDDST. Measurement of dexamethasone improved diagnostic accuracy of the test.